World's Best Scientists 2026 revealed!
Clinical and Translational Immunology
H-index 39

Clinical and Translational Immunology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Immunology 47 212 199 31
Medicine 620 166 160 31

Additional Metrics

Number of Best Scientists*: 459
Documents by Best Scientists*: 308
Top 100 Ranked Scientists*: 15
SCIMAGO H-index: 60
SCIMAGO SJR: 1.472
Impact Factor: 3.8

Overview

Top Research Topics at Clinical And Translational Immunology?

The concepts of Immunology, Immune system, Immunity, Antibody and Antigen are tackled in the journal. Issues in Immunology were discussed, taking into consideration concepts from other disciplines like Cytotoxic T cell and Disease. Immune system research featured in it incorporates concerns from various other topics such as Cytokine and Allergy.

While Immunity is the focus of Clinical And Translational Immunology, it also provided insights into the studies of Gut flora and Vaccination. Antibody research presented in the journal encompasses a variety of subjects, including Virus and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The majority of Antigen studies in the journal are focused on the subject of Epitope.

The work on Immunotherapy tackled in Clinical And Translational Immunology brings together disciplines like Tumor microenvironment and Cancer research. It focused on Chimeric antigen receptor research but expanded to cover Cell therapy.

  • Immunology (99.80%)
  • Immune system (47.34%)
  • Immunity (17.42%)

What are the most cited papers published in the journal?

  • Regulation of immune cell function by short-chain fatty acids (466 citations)
  • Toll-like receptors: the swiss army knife of immunity and vaccine development (160 citations)
  • Dengue virus antibodies enhance Zika virus infection (146 citations)

Research areas of the most cited articles at Clinical And Translational Immunology:

The most cited publications mostly deal with topics like Immunology, Immune system, Immunity, Disease and Antibody. The journal articles address concerns in Immune system which are intertwined with other disciplines, such as Cancer, Autoimmune disease, Receptor and Virology. The published articles focus on Disease but the discussions also offer insight into other areas such as Microbiome and Pathogenesis.

What topics the last edition of the journal is best known for?

  • Immune system
  • Gene
  • Internal medicine

The previous edition focused in particular on these issues:

The journal focuses on Immunology, Immune system, Antibody, Immunity and CD8. The journal holds forums on Immunology that merges themes from other disciplines such as Cytotoxic T cell and Disease. Immune system research in the journal involves the investigation of Lung studies, all of which are linked to disciplines such as Respiratory system.

While it focused on Antibody, it was also able to explore topics like Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Coronavirus disease 2019 (COVID-19). The Immunity research presented in Clinical And Translational Immunology explores the relationship between Vaccination and the closely related topic of Viral load and Virus. The tackled CD8 research is interrelated with T cell which concerns subjects like Cellular immunity.

The most cited articles from the last journal are:

  • Pattern of circulating SARS‐CoV‐2‐specific antibody‐secreting and memory B‐cell generation in patients with acute COVID‐19 (10 citations)
  • Influenza, but not SARS-CoV-2, infection induces a rapid interferon response that wanes with age and diminished tissue-resident memory CD8+ T cells (8 citations)
  • Arrested development: suppression of NK cell function in the tumor microenvironment. (8 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Clinical And Translational Immunology (based on the number of publications) are:

  • Corey Smith (8 papers) published 2 papers at the last edition the same number as at the previous edition,
  • Rajiv Khanna (8 papers) published 1 paper at the last edition, 2 less than at the previous edition,
  • Lisa F. P. Ng (7 papers) published 1 paper at the last edition, 3 less than at the previous edition,
  • Phillip K. Darcy (7 papers) absent at the last edition,
  • Mark J. Smyth (6 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Clinical And Translational Immunology (based on the number of publications) are:

  • University of Melbourne (47 papers) published 12 papers at the last edition, 3 more than at the previous edition,
  • University of Queensland (41 papers) published 17 papers at the last edition, 7 more than at the previous edition,
  • Monash University (30 papers) published 6 papers at the last edition, 2 less than at the previous edition,
  • QIMR Berghofer Medical Research Institute (27 papers) published 2 papers at the last edition, 4 less than at the previous edition,
  • University of Western Australia (21 papers) published 3 papers at the last edition, 5 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 1.75% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 32.14% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.61% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 16.96% of all publications and 39.29% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination

    Unknown

    (2022)
    182 Citations
  • Plasmacytoid dendritic cell biology and its role in immune-mediated diseases

    Yishan Ye;Yishan Ye;Béatrice Gaugler;Mohamad Mohty;Florent Malard

    (2020)
    144 Citations
  • Immune microenvironment composition in non-small cell lung cancer and its association with survival.

    Menno Tamminga;Thijo Jeroen N. Hiltermann;Ed Schuuring;Wim Timens

    (2020)
    139 Citations
  • Antibodies against type I interferon: detection and association with severe clinical outcome in COVID-19 patients.

    David Goncalves;Mehdi Mezidi;Paul Bastard;Paul Bastard;Paul Bastard;Magali Perret

    (2021)
    94 Citations
  • Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

    Chuanhao Jiang;Yali Wang;Min Hu;Lingjun Wen

    (2020)
    71 Citations
  • Regulatory T cells in solid organ transplantation.

    Muhammad Atif;Filomena Conti;Guy Gorochov;Ye Htun Oo;Ye Htun Oo

    (2020)
    65 Citations
  • Increased IL-10-producing regulatory T cells are characteristic of severe cases of COVID-19.

    Julika Neumann;Teresa Prezzemolo;Lore Vanderbeke;Carlos P Roca

    (2020)
    63 Citations

Related Online Degrees & Career Pathways

For those interested in advancing their medical careers in the USA, exploring related online degrees can open new doors. Many healthcare professionals start with nursing and then build their qualifications through fast-track programs. For example, the fastest rn to bsn program options allow registered nurses to quickly obtain a Bachelor of Science in Nursing, boosting both knowledge and job prospects.

Nurses aiming for higher responsibility roles often consider nursing practitioner career paths. Online rn to np programs offer a bridge from an Associate Degree in Nursing to a Master of Science in Nursing with a nurse practitioner focus, allowing for advanced practice and specialized care roles.

For individuals without a nursing background, direct entry msn programs provide an accelerated pathway to earn a Master of Science in Nursing. These programs are designed to prepare non-nurses for licensure and clinical practice quickly and efficiently.

When choosing the best online routes to advance, it’s important to compare program quality and flexibility. The detailed capella vs chamberlain rn to bsn comparison highlights key differences in curriculum, cost, and support, helping students pick the right fit for their educational and career goals.

Best Scientists Contributing to This Journal